Home / Resource Library / An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/Lymphoma

An Open-Label, Multicenter, Phase II Study of Bexarotene in Patients With Adult T-Cell Leukemia/Lymphoma

Results of a study examining bexarotene for treatment of adult t-cell lymphoma.